Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Novel Small Molecule Targeting the Hemagglutinin Stalk of Influenza Viruses

Authors
Kim, Jin IlLee, SangmooLee, Gong YealPark, SeheeBae, Joon-YongHeo, JunKim, Hong-YoubWoo, Seok-HunLee, Hae UnAhn, Chung AmBang, Hye JinJu, Hyun SooOk, KiwonByun, YoungjooCho, Dae-JinShin, Jae SooKim, Dong-YeonPark, Mee SookPark, Man-Seong
Issue Date
9월-2019
Publisher
AMER SOC MICROBIOLOGY
Keywords
hemagglutinin stalk; membrane fusion; small molecule; antiviral agents; influenza virus
Citation
JOURNAL OF VIROLOGY, v.93, no.17
Indexed
SCIE
SCOPUS
Journal Title
JOURNAL OF VIROLOGY
Volume
93
Number
17
URI
https://scholar.korea.ac.kr/handle/2021.sw.korea/63009
DOI
10.1128/JVI.00878-19
ISSN
0022-538X
Abstract
Combating influenza is one of the perennial global public health issues to be managed. Antiviral drugs are useful for the treatment of influenza in the absence of an appropriate vaccine. However, the appearance of resistant strains necessitates a constant search for new drugs. In this study, we investigated novel anti-influenza drug candidates using in vitro and in vivo assays. We identified anti-influenza hit compounds using a high-throughput screening method with a green fluorescent protein-tagged recombinant influenza virus. Through subsequent analyses of their cytotoxicity and pharmacokinetic properties, one candidate (IY7640) was selected for further evaluation. In a replication kinetics analysis, IY7640 showed greater inhibitory effects during the early phase of viral infection than the viral neuraminidase inhibitor oseltamivir. In addition, we observed that hemagglutinin (HA)-mediated membrane fusion was inhibited by IY7640 treatment, indicating that the HA stalk region, which is highly conserved across various (sub) types of influenza viruses, may be the molecular target of IY7640. In an escape mutant analysis in cells, amino acid mutations were identified at the HA stalk region of the 2009 pandemic H1N1 (pH1N1) virus. Even though the in vivo efficacy of IY7640 did not reach complete protection in a lethal challenge study in mice, these results suggest that IY7640 has potential to be developed as a new type of anti-influenza drug. IMPORTANCE Anti-influenza drugs with broad-spectrum efficacy against antigenically diverse influenza viruses can be highly useful when no vaccines are available. To develop new anti-influenza drugs, we screened a number of small molecules and identified a strong candidate, IY7640. When added at the time of or after influenza virus infection, IY7640 was observed to successfully inhibit or reduce viral replication in cells. We subsequently discovered that IY7640 targets the stalk region of the influenza HA protein, which exhibits a relatively high degree of amino acid sequence conservation across various (sub) types of influenza viruses. Furthermore, IY7640 was observed to block HA-mediated membrane fusion of H1N1, H3N2, and influenza B viruses in cells. Although it appears less effective against strains other than H1N1 subtype viruses in a challenge study in mice, we suggest that the small molecule IY7640 has potential to be optimized as a new anti-influenza drug.
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Medical Science > 1. Journal Articles
College of Pharmacy > Department of Pharmaceutical Science > 1. Journal Articles
Graduate School > Department of Biomedical Sciences > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Park, Man Seong photo

Park, Man Seong
의과학과
Read more

Altmetrics

Total Views & Downloads

BROWSE